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Europe plays a major role in the international semi-
conductor industry, but has conducted few studies of
the occupational health of its workers. An exception is
in the United Kingdom, where, in two small studies, the
Health and Safety Executive (HSE) evaluated some
health effects of semiconductor work. Neither of these
studies, largely restricted to Scotland, produced defini-
tive results, and both were misused by industry to assert
that they demonstrated no adverse health effect on
workers. The results of the studies prompted semicon-
ductor industry inspections recently completed by the
HSE that included chip manufacturers in Scotland and
other U.K. areas. The results of these inspections are
disappointing. Key words: semiconductor industry;
Health and Safety Executive; electronics industry.
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Scotland is a major European center for semicon-ductor and other computer electronics. Scotlandbegan with a wartime electronics industry in the
1940s that subsequently brought investments by
Motorola, IBM, NCR, and Honeywell. Scotland now
produces about 30% of Europe’s personal computers
and 80% of its workstations. It provides almost half of
the semiconductors made in the United Kingdom,
amounting to 7% of the total European production.
There are over 10,000 employees in the semiconductor
industry in Scotland, and almost double that number
in optoelectronics and communications technologies.
The major semiconductor companies are Motorola,
Intel, Semefab, National Semiconductor, Cadence
Design Systems, IBM, Axeon, Epson, and Nallatech.1
National Semiconductor’s wafer-manufacturing plant
in Greenock, Scotland, started production in 1970 and
currently employs about 600 workers. At one time the
plant employed more than 2,000 workers. The Greenock
plant had been equipped with equipment from the
United States and, according to former employees, had
frequent incidents of gas and chemical exposures of
workers in the cleanroom. Women workers grew increas-
ingly concerned about a number of health effects and ini-
tiated lawsuits for compensation for their illnesses and for
their loss of work. Many of the women belong to an
organization called Phase Two, and their litigation may
soon appear in a Scottish court or be settled outside of
court. In 1998 about 50 workers filed a class action lawsuit
against the plant, demanding compensation for cancer,
birth defects in their children, undue miscarriages, and
other illnesses. A similar group of workers organized at
Motorola’s East Kilbride plant near Glasgow.
HSE REPRODUCTIVE STUDY
In response apparently to pressure from ex-workers,
media coverage, and the growing number of litigants, the
U.K. government’s Health and Safety Executive (HSE)
conducted a study of the spontaneous abortion rate of
women working at six semiconductor plants in the
United Kingdom. It announced the results in 1998 and
concluded that there was no convincing evidence that
work in the U.K. semiconductor industry shared the U.S.
problem with increased abortion rates.2 This study was
heavily criticized on several points, including the small
number of workers included in the study and the lack of
distinction between people working in the cleanrooms
and those performing jobs without chemical exposures.3
The study was of such small size that no statistically reli-
able results were presented to support the HSE position
that they had demonstrated an absence of risk. 
HSE CANCER STUDY
In late 2001 the HSE announced the results of its study
of cancer mortality in a small sample of workers at the
National Semiconductor (NSUK) plant at Greenock,
Scotland. The HSE Cancer Study found that the over-
all mortality rate from all causes of death was lower
among workforce members than it was for Scotland as
a whole, though the total incidence of cancer cases was
about the same as for Scotland as a whole. However, the
HSE identified higher-than-expected incidences of
three particular types of cancer among women in the
workforce and one type in men.
There were 11 cases of lung cancer in women—two
to three times as many as expected. Three cases of
stomach cancer occurred in women—four or five times
as many as expected. There were 20 cases of breast
cancer—five more than would have been expected.
Three deaths from brain cancer occurred among
men—about four times as many as would be expected.
No important excesses of any other types of cancer
investigated were identified.4
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The HSE study used only a very small group of
employees, and a substantial fraction of them had little
or no exposure to the chemicals of concern. The HSE
investigators simply defined all NSUK Greenock employ-
ees as subjects, thereby seriously limiting the opportuni-
ties to demonstrate increased cancer risks in the workers
who were most heavily exposed. The small sample size
was of concern to many of us who reviewed the HSE
study proposal. Still, the results substantially reinforce
the concerns that prompted the investigation and sug-
gest a work-related cause for several kinds of cancer.5
It is remarkable that four apparent excesses in
cancer were found in a study with a weak study design
and a total of only 71 deaths. However, the relative risks
are still subject to very wide uncertainty, and the range
of effects (including other cancers and other causes of
death) may be substantially larger than present data
indicate. Cancer is fairly common at three of the sites
reported (excepting brain), and important but small
increases in less common sites could have been missed
simply because the study was too small to detect them.
The somewhat reduced total mortality (presumably a
healthy-worker effect), with a near-average cancer reg-
istration rate, suggests the possibility of some real ele-
vation in the cancer risks over what these specific work-
ers might otherwise have experienced. 
HSE INSPECTION OF U.K.
SEMICONDUCTOR MANUFACTURERS
When the HSE published the results of its study of
cancer at NSUK in Greenock, it announced that it
would inspect all U.K. semiconductor plants over the
course of the following year. The HSE inspected 25
plants operated by 22 different companies in the
United Kingdom in 2002. At first glance, the inspection
report appeared to disclose a number of deficiencies in
health and safety programs in the industry. Twenty-two
percent of the plants failed to meet “minimum legal
requirements” for health provision, ventilation, and
health surveillance. Only five plants complied with
minimum legal requirements for every issue inspected.
As a result, the HSE issued 13 improvement notices and
one prohibition notice to five of the companies.6
Of 14 notices issued against the semiconductor and
related companies in the 2002 HSE inspections, 12
were against Scottish companies yet only five of the 22
companies inspected were Scottish. Four of these five
Scottish companies shared 12 of the total of 14 notices
issued across England, Scotland, and Wales.6
HSE inspectors were critical of the standard of occu-
pational health services. Many of the plant physicians
and nurses used by the companies were part-time and
were employed by outside entities, not by the compa-
nies. Most of the doctors were general practitioners,
some of whom had never even visited the plants. In the
case of arsenic, a carcinogen widely used by British
semiconductor companies, HSE found that plant “sur-
face cleanliness, particularly arising from potential
exposure to arsenic in cleaning and refurbishment of
ion implant sources, needs to be addressed.”6
Nonetheless, the HSE reported its findings in
euphemistic terms intended to show that there are no
serious failures to meet U.K. industrial standards. This
is easily challenged since the inspection was so limited
in scope and depth. The HSE appears not to have had
the funds to perform a comprehensive inspection. No
occupational hygiene sampling was conducted by the
HSE, and no internal company occupational hygiene
data were provided to the inspectors. It is not possible
to evaluate the semiconductor industry without obtain-
ing worker exposure assessments. By apparently failing
to measure the ambient levels of chemical fumes and
vapors (including a number of known carcinogens) in
the cleanrooms, according to the 2002 Report, the HSE
shares with the semiconductor companies what we view
as a substandard practice of health and safety inspec-
tion and reporting. Few companies will bother to
change their internal policies on health and safety
given the superficiality of inspection by the agency
responsible for enforcing health and safety regulations.
The processes selected by the HSE for particular
attention, “were mainly where carcinogens or suspected
carcinogens were likely to be used in semiconductor
manufacture.” The processes selected, however, do not
include the application and development of photore-
sists, a serious omission since assessment of exposures to
carcinogens is a major goal of the inspection. The expo-
sure of workers to ionizing and non-ionizing radiation
went without inspection or consideration. To make mat-
ters worse, the inspectors came to the conclusion that
arsenic is the only Class 1 carcinogen handled by the
companies, and that there are “no specific minimum
legal requirements for surface cleanliness and compa-
nies should set in-house standards to be achieved.” The
worker exposure to arsenic was not ascertained by the
HSE since no sampling (air or surface) was performed.
No mention is made in the inspection report of any car-
cinogens other than arsenic, of which there are many in
semiconductor cleanrooms. Moreover, the exposures of
cleanroom workers to chemical mixtures and reactant
products were not assessed or discussed.
Such superficial inspection procedures then allowed
the HSE to conclude that there is “no definite proof
that working at the plant has caused an increased risk of
employees developing cancer.” The inspection was an
inadequate appraisal of exposures to carcinogens, and
can conclude nothing of the sort. Moreover, the inspec-
tions add nothing that would allow the HSE to change
its interpretation of the HSE Cancer Study results. A
problem with occupational cancer in semiconductor
workers has been demonstrated and reported by the
HSE and the problem cannot be dismissed until a more
definitive epidemiologic study has been conducted.
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The inspection report contains many statements
that demonstrate a lack of understanding of the
worker-exposure problems encountered in the semi-
conductor industry. Ventilation is evaluated by HSE
inspectors as if the semiconductor cleanroom were just
another manufacturing setting. In a cleanroom, hun-
dreds of air exchanges are taking place each hour. The
work environment requires much more expertise than
the inspection of conventional ventilation systems. The
HSE inspected semiconductor cleanrooms merely for
standard violations of “equipment not working to
design specification.” Yet even at this weak standard of
acceptability, “ventilation was found to be a problem at
a large number of inspections.” 
The HSE inspection found that the semiconductor
industry in the United Kingdom relies on local general
practitioners (GPs) or family practice doctors who
seldom, if ever, work in the plants to provide occupa-
tional medicine services; these norromally are not
accredited specialists in occupational medicine. They
conduct pre-employment examinations of unknown
completeness, and evaluate workers who are injured or
made ill while at work. The details of worker illnesses
and injuries are not made public, and the extent to
which the physicians communicate with the employers
is not known. Nurses who work in the plants are not
subject to evaluations of their quality or competence
except by the GPs, who are selected by management.
Health and safety personnel, when adequately trained
and experienced, ought to be part of the preventive
health and safety program development of each com-
pany. There is little reason to believe, on the evidence
available, that this ever occurs in the plants inspected
by the HSE. It appears that some companies may thus
be able to evade regulation, enforcement, and often
any meaningful external occupational health and
safety review of their work. The implications of these
types of failings are that chronic illnesses in the workers
could develop unhnoticed and unrecorded. Such fail-
ings can and should be rapidly remedied. 
Many of the most serious problems of worker expo-
sure in the semiconductor industry were not addressed
at all. The inspection demonstrated little beyond the
HSE conclusion that the semiconductor industry is,
“comparable with many other manufacturing industries
with some very good practice and some areas where
improvements could, and sometimes should, be made.
Most companies were close to or complied with mini-
mum legal requirements.” In an industry that has been
demonstrated by the HSE to have an unexplained occu-
pational cancer risk, this is not nearly adequate inspec-
tion and reporting. Nonetheless, the HSE inspection of
the semiconductor industry’s health and safety pro-
grams demonstrates that these company programs are in
need of significant improvements. The HSE itself has
recently acknowledged that in 2001– 2002, of the 40 mil-
lion working days lost through occupational injury and
disease, 33 million were attriirbutable to ill-health prob-
lems.9 This would indicate that U.K. good practice rela-
tive to occupational health may well be poor practice.
MISSED OPPORTUNITIES AND FLAWED
PAST PRACTICES
Labor inspectors play an important role in protecting
workers in any industry. With limited time and
resources, and what appears to be a lack of detailed
knowledge about occupational health and safety in the
semiconductor industry, HSE Inspectors are assigned a
difficult task. Moreover, HSE inspectors are seriously
underfunded and understaffed, and face further cuts,
with a possibility of losing 50 field inspectors in 2003.7
There are serious flaws in the process, analysis, and
conclusions of the HSE inspection report. It is disap-
pointing that there is little evidence of the HSE effec-
tively enforcing regulations in an industry that appears
to have evaded rigorous and comprehensive inspec-
tions in the past. Not surprisingly, the semiconductor
industry viewed the 2002 HSE inspection report as “a
demonstration that overall compliance with health and
safety legislation was comparable with many other
industries.”8 For an industry that considers itself to be
at the leading edge of science and technology, this is
not a ringing endorsement of its health and safety pro-
grams. The report could also be viewed as a knee-jerk
reaction by the HSE to adverse publicity resulting from
the HSE Cancer Study. There are few signs at a senior
management level that the HSE has learned from its
own past failures. Moreover, the HSE does not appear
to be adopting better industry-wide strategies. 
The HSE expresses “reasonable confidence” in com-
pany management in the semiconductor industry. The
basis for this opinion remains unsubstantiated in the
report. In Scotland, there is a significant disparity
between what the semiconductor industry indicated were
sound health and safety practices in the 1980s and 1990s
and what many former workers remember to be the case.
The 2002 HSE inspection report makes no mention of
any earlier inspections carried out by the HSE in these
plants. Hence we have no baseline data and cannot assess
whether the semiconductor industry has improved or
worsened its health and safety standards and practices. 
The HSE inspection resulted, in part, from pressures
exerted by former workers and their representatives. This
is a disappointing demonstration of HSE passivity and
perhaps reflects the wider malaise within HSE in address-
ing high-technology industries. Lack of transparency and
a failure to address past practices appear to be hallmarks
of the HSE. An inspection strategy needs to be developed
that includes not just employers and HSE staff, but also
employees, trade unions, and groups such as Phase Two.
The selection of locations to be inspected appears to
be a relatively random process. A purposive sample
drawing on past reports and incident cases in semicon-
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ductor plants could well have produced more mean-
ingful results. HSE selection criteria are not available to
readers of the report. It would be useful to know who
advised on the selection process and what input there
was from employees and their representatives. 
The report suggests that notices of some or all of the
inspections were telegraphed to the companies and
hence gave the companies time to prepare for the inspec-
tors. The HSE has often stated that this practice simply
means more effective and efficient use of HSE time and
resources. Employees often feel that such a practice pro-
vides employers with every opportunity to rectify or hide
the worst of their deficient occupational health and safety
practices. If so, the inspection report may well present
not true working conditions in the semiconductor indus-
try, but rather a best practice of the companies inspected.
The methods used by the HSE to select industrial
processes to inspect or investigate are not contained in
the report. It is not clear whether the HSE looked at
teratogens as well as a select group of carcinogens.
Since the HSE has not addressed the issue of birth
defects in its studies, it may be that it does not consider
them to be important health problems. No indication
is provided on how the HSE assessed potential health
problems resulting from exposures to chemical mix-
tures. Since there is so little known about some chemi-
cals and possible chemical mixtures, were these poten-
tial problems simply omitted or ignored?
The action plan at the end of the document indi-
cates that chemical handling is deficient. It follows that
such deficiencies and the need for significant improve-
ments indicate significant past legal and technical fail-
ures of occupational hygiene, health and safety man-
agement, and health surveillance. These failures lay
with the HSE as well as the industry.
The HSE indicates that they used “procedures” to
assess occupational health and safety effectiveness that
in the context of risk-control indicators were new to the
inspectors carrying out the work. Procedures do not
assess effectiveness at all. They are all too often paper
exercises that do not evaluate practice, and it is possi-
ble to hoodwink inspection teams that rely heavily on
paper trails. The rating of “best practice” does not fit
with the HSE emphasis on procedures. What is best
practice based upon and what evidence was used to
support it? The HSE report does not provide any of this
information, so it is an untested technique in this set-
ting with no evidence base. 
The HSE indicates that the semiconductor industry
lacks the means to carry out health surveillance prop-
erly. If the industry cannot carry out effective health
surveillance, how can the industry and the HSE argue
that occupational health was satisfactory in the indus-
try? The sections dealing with monitoring appear to
indicate both past failures of the industry and past fail-
ures of the HSE to properly inspect the industry. The
report casts doubt on earlier HSE assessments about
occupational hygiene practice being satisfactory. The
companies apparently do not and did not have records
of chemical exposures because as far as we know no
occupational hygiene sampling was conducted or
reported. These failings are highly unlikely to have just
occurred but rather are more likely to reflect cultural,
organizational, and systems failures in the industry.
The HSE readily admits that enforcement in the
industry is a “complex” issue. This is used as a justifica-
tion by the HSE for what often resulted in verbal advice
and letters from the HSE to manufacturers on occupa-
tional health and safety matters, even when regulations
were being violated. The HSE recognized the flawed
approach of the inspection, and provides some recog-
nition of the failure of past HSE inspections of the
industry. The shortcomings in the HSE appear to be
the result of apathy, complacency, underfunding, and
an industry fairly secure in the belief that it will not be
regularly and rigorously inspected, and even if it will,
not much in terms of punitive enforcement will occur.
CONCLUSION
The HSE is creating the illusion that the semiconductor
industry in the United Kingdom is being rigorously
inspected and regulated, and that it is the subject of
extensive research efforts intended to protect the health
of its workers. The results of government regulatory and
enforcement efforts, and of its occupational health
research to date, fall far short of supporting such asser-
tions. The United Kingdom needs to make a greater
effort to improve occupational health and safety than it
does, and to fund the HSE to properly safeguard work-
ers. The rest of Europe needs to join the United King-
dom in assuring the health and safety of semiconductor
workers. Many European countries should join in the
effort to protect high-technology electronics workers.
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